Want to see JP:2927 full AI Analyst Report?
AFC-HD AMS Life Science Co., Ltd. (2927) Financial Statements
AFC-HD AMS Life Science Co., Ltd. Financial Overview
AFC-HD AMS Life Science Co., Ltd.'s market cap is currently $12.09B. The company's EPS TTM is $82.98; its P/E ratio is 10.28; and it has a dividend yield of 4.69%. AFC-HD AMS Life Science Co., Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Aug 26 | Aug 25 | Aug 24 | Aug 23 | Aug 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 34.32B | $ 32.66B | $ 30.19B | $ 25.58B | $ 23.00B |
| Gross Profit | $ 11.65B | $ 10.97B | $ 10.49B | $ 9.32B | $ 8.58B |
| Operating Income | $ 2.45B | $ 2.38B | $ 1.92B | $ 1.64B | $ 1.02B |
| EBITDA | $ 3.92B | $ 3.80B | $ 3.10B | $ 2.59B | $ 2.30B |
| Net Income | $ 1.20B | $ 1.45B | $ 1.25B | $ 1.10B | $ 735.35M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 9.76B | $ 11.30B | $ 12.17B | $ 11.18B | $ 10.38B |
| Total Assets | $ 49.05B | $ 48.73B | $ 47.03B | $ 41.07B | $ 37.35B |
| Total Debt | $ 23.41B | $ 24.14B | $ 23.40B | $ 19.59B | $ 17.24B |
| Net Debt | $ 13.65B | $ 12.84B | $ 11.22B | $ 8.40B | $ 6.86B |
| Total Liabilities | $ 32.61B | $ 33.53B | $ 33.07B | $ 27.91B | $ 24.90B |
| Stockholders' Equity | $ 16.21B | $ 15.08B | $ 13.93B | $ 13.11B | $ 12.44B |
| Cash Flow | |||||
| Free Cash Flow | $ -726.43M | $ -1.75B | $ -1.87B | $ -1.07B | $ 534.45M |
| Operating Cash Flow | $ 1.68B | $ 1.79B | $ 1.54B | $ 865.28M | $ 1.49B |
| Investing Cash Flow | $ -2.85B | $ -3.33B | $ -2.76B | $ -1.95B | $ -1.08B |
| Financing Cash Flow | $ -616.99M | $ 666.75M | $ 2.23B | $ 1.88B | $ 1.16B |
Currency in JPY